Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer

Background: It is not known whether androgen ablation therapy (AAT) influences TRAIL death ligand and its receptors expression of prostate cancer (PCa) cells. Aim: To investigate whether hormonal therapy alters the expression of TRAIL death ligand and TRAIL receptors in patients with advanced PCa. P...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urologia internationalis 2010-01, Vol.84 (4), p.445-451
Hauptverfasser:	Koksal, Ismail Turker, Sanlioglu, Ahter Dilsad, Kutlu, Omer, Sanlioglu, Salih
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Drug Resistance, Neoplasm Humans Immunohistochemistry Male Neoplasm Staging Original Paper Prostatic Neoplasms - drug therapy Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism Receptors, Tumor Necrosis Factor - metabolism Time Factors TNF-Related Apoptosis-Inducing Ligand - metabolism Treatment Outcome Turkey
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!